Ascentage Pharma Group International (FRA:36X)
€ 3.8 -0.040 (-1.04%) Market Cap: 1.54 Bil Enterprise Value: 1.48 Bil PE Ratio: 0 PB Ratio: 9.92 GF Score: 68/100

Full Year 2025 Ascentage Pharma Group International Earnings Presentation Transcript

Mar 26, 2026 / 12:00PM GMT
Release Date Price: €4.62 (-3.35%)

Mar 26, 2026 / 12:00PM GMT
Presentation
Mar 26, 2026 / 12:00PM GMT

=====================
Corporate Participants
=====================
* Yuly Chen
Ascentage Pharma Group International - Senior Director of Investor Relations
* Dajun Yang
Ascentage Pharma Group International - Executive Chairman of the Board, Chief Executive Officer, Co-Founder
* Veet Misra
Ascentage Pharma Group International - Chief Financial Officer
* Zhichao Si
Ascentage Pharma Group International - Head of Commercial

=====================
Conference Call Participants
=====================
* Brian Cheng
JPMorgan Chase & Co - Analyst
* Biren Amin
Piper Sandler - Analyst
* Supawat Thongthip
Truist Securities - Analyst
* Jeet Mukherjee
BTIG LLC - Equity Analyst
* Matthew Biegler
Oppenheimer & Co Inc - Analyst
* Christopher Liu
Lucid Capital Markets LLC - Analyst
* Michael King
Rodman & Renshaw - Analyst

=====================
Operator

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
7-Day Free Trial · Cancel Anytime
Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot